Abstract
Effect of nintedanib on decline in forced vital capacity (FVC) over time in the INPULSIS trials in patients with idiopathic pulmonary fibrosis (IPF)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have